Intravacc Revenue and Competitors

Bilthoven,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Intravacc's estimated annual revenue is currently $20.8M per year.(i)
  • Intravacc's estimated revenue per employee is $155,000

Employee Data

  • Intravacc has 134 Employees.(i)
  • Intravacc grew their employee count by 2% last year.

Intravacc's People

NameTitleEmail/Phone
1
VP Business Development & MarketingReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
System AdministratorReveal Email/Phone
4
onderzoeksmedewerkerReveal Email/Phone
5
Facilitair coördinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Intravacc?

Even the most promising vaccines don't always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies. As an established independent DVMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials in humans. Part of Utrecht Science Park Bilthoven

keywords:N/A

N/A

Total Funding

134

Number of Employees

$20.8M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Intravacc News

2022-03-22 - Intravacc publishes GMP vaccine candidate manufacturing ...

Intravacc has published the good manufacturing practice (GMP) manufacturing and ... SF2a vaccine production process, according to Intravacc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M3169%N/A